127 related articles for article (PubMed ID: 466727)
1. Comparative cytotoxic and antitumoral effects of ellipticine derivatives on mouse L 1210 leukemia.
Paoletti C; Cros S; Xuong ND; Lecointe P; Moisand A
Chem Biol Interact; 1979 Apr; 25(1):45-58. PubMed ID: 466727
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of tumor cell growth in vitro and in vivo by 2-methyl 9-hydroxyellipticinium entrapped within phospholipid vesicles.
Sautereau AM; Cros S; Tocanne JF
Biopharm Drug Dispos; 1986; 7(4):357-71. PubMed ID: 3768491
[TBL] [Abstract][Full Text] [Related]
3. Some antitumor derivatives of ellipticine deprived of mutagenic properties.
Lecointe P; Lesca P; Cros S; Paoletti C
Chem Biol Interact; 1978 Jan; 20(1):113-21. PubMed ID: 630641
[TBL] [Abstract][Full Text] [Related]
4. [2 new antineoplastic derivatives: 9-hydroxy-2-methyl-ellipticinium (acetate) and 9-hydroxy-2,6-dimethyl-ellipticinium (chloride). Effect on mouse L 1210 leukemia].
Le Pecq JB; Gosse C; Nguyen-Dat-Xuong ; Paoletti C
C R Acad Hebd Seances Acad Sci D; 1975 Nov; 281(18):1365-7. PubMed ID: 815025
[TBL] [Abstract][Full Text] [Related]
5. Topoisomerase II-mediated DNA cleavage activity induced by ellipticines on the human tumor cell line N417.
Multon E; Riou JF; LeFevre D; Ahomadegbe JC; Riou G
Biochem Pharmacol; 1989 Jul; 38(13):2077-86. PubMed ID: 2544183
[TBL] [Abstract][Full Text] [Related]
6. Protein-associated deoxyribonucleic acid strand breaks produced in mouse leukemia L1210 cells by ellipticine and 2-methyl-9-hydroxyellipticinium.
Zwelling LA; Michaels S; Kerrigan D; Pommier Y; Kohn KW
Biochem Pharmacol; 1982 Oct; 31(20):3261-7. PubMed ID: 7150355
[No Abstract] [Full Text] [Related]
7. Ellipticine derivatives with an affinity to the estrogen receptor, an approach to develop intercalating drugs with a specific effect on the hormone-dependent breast cancer.
Delbarre A; Oberlin R; Roques BP; Borgna JL; Rochefort H; Le Pecq JB; Jacquemin-Sablon A
J Med Chem; 1985 Jun; 28(6):752-61. PubMed ID: 4009597
[TBL] [Abstract][Full Text] [Related]
8. [Syntheses designed to produce 8-amino ellipticine. Synthesis and pharmacological properties of 8-nitro ellipticine].
Gansser C; Lévque X; Plat M; Viel C
Farmaco Sci; 1982 May; 37(5):283-97. PubMed ID: 7095141
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic effects of the lysosomotropic agents DNA-ellipticine, DNA-daunorubicin, and DNA-ellipticine:daunorubicin on L1210 leukemia cells.
Sorace RA; Sheid B
Cancer Treat Rep; 1979 Jan; 63(1):43-51. PubMed ID: 421232
[No Abstract] [Full Text] [Related]
10. [9-Nitro- and 9-amino-ellipticines and derivatives: synthesis and pharmacologic properties].
Gansser C; Viel C; Malvy C; Cros S
Farmaco Sci; 1980 Nov; 35(11):887-95. PubMed ID: 7450021
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships in a series of newly synthesized 1-amino-substituted ellipticine derivatives.
Ducrocq C; Wendling F; Tourbez-Perrin M; Rivalle C; Tambourin P; Pochon F; Bisagni E; Chermann JC
J Med Chem; 1980 Nov; 23(11):1212-6. PubMed ID: 7452670
[TBL] [Abstract][Full Text] [Related]
12. Ellipticine and derivatives induce breakage of L1210 cells DNA in vitro.
Paoletti C; Lesca C; Cros S; Malvy C; Auclair C
Biochem Pharmacol; 1979; 28(3):345-50. PubMed ID: 426849
[No Abstract] [Full Text] [Related]
13. Interrelationship between affinity for DNA, cytotoxicity and induction of DNA-breaks in cultured L1210 cells for two series of tricyclic intercalators. Simplified analogues of ellipticine derivatives.
Pierson V; Pierre A; de Cointet P; Nguyen CH; Bisagni E; Gros P
Biochem Pharmacol; 1989 May; 38(9):1395-406. PubMed ID: 2719718
[TBL] [Abstract][Full Text] [Related]
14. Ellipticine, 9-hydroxyellipticine, and 9-hydroxyellipiticinum: some biochemical properties of possible pharmacologic significance.
Paoletti C; Auclair C; Lesca P; Tocanne JF; Malvy C; Pinto M
Cancer Treat Rep; 1981; 65 Suppl 3():107-18. PubMed ID: 7049365
[TBL] [Abstract][Full Text] [Related]
15. N-methylcarbamate derivatives of ellipticine and olivacine with cytotoxic activity against four human lung cancer cell lines.
Ruckdeschel JC; Modi SP; el-Hamouly W; Portuese E; Archer S
J Med Chem; 1992 Dec; 35(26):4854-7. PubMed ID: 1479585
[TBL] [Abstract][Full Text] [Related]
16. Physicochemical and pharmacological properties of the antitumor ellipticine derivative 2-(diethylamino-2-ethyl)9-hydroxy ellipticinium-chloride, HCl.
Auclair C; Pierre A; Voisin E; Pepin O; Cros S; Colas C; Saucier JM; Verschuere B; Gros P; Paoletti C
Cancer Res; 1987 Dec; 47(23):6254-61. PubMed ID: 3677074
[TBL] [Abstract][Full Text] [Related]
17. Potential antitumor agents: synthesis and biological properties of aliphatic amino acid 9-hydroxyellipticinium derivatives.
Auclair C; Voisin E; Banoun H; Paoletti C; Bernadou J; Meunier B
J Med Chem; 1984 Sep; 27(9):1161-6. PubMed ID: 6471070
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of 9-hydroxyellipticine (NSC 210717) ON L1210 mouse leukemia and the effect of route of injection.
Le Pecq JB; Gosse C; Nguyen-Dat-Xuong ; Cros S; Paoletti C
Cancer Res; 1976 Sep; 36(9 pt.1):3067-76. PubMed ID: 975074
[TBL] [Abstract][Full Text] [Related]
19. Effects of ellipticine on cell survival and cell cycle progression in cultured mammalian cells.
Traganos F; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
Cancer Res; 1980 Jul; 40(7):2390-9. PubMed ID: 6155993
[TBL] [Abstract][Full Text] [Related]
20. Relationships between physicochemical and biological properties in a series of oxazolopyridocarbazole derivatives (OPCd); comparison with related anti-tumor agents.
Auclair C; Schwaller MA; René B; Banoun H; Saucier JM; Larsen AK
Anticancer Drug Des; 1988 Aug; 3(2):133-44. PubMed ID: 2841946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
